This statement applies to the public website at cortexr.io. It does not cover the separate clinical portal at portal.cortexr.io.

Accessibility standard

The site is being built to meet the Web Content Accessibility Guidelines version 2.2 at level AA. We also use the NHS service manual accessibility guidance and NHS accessibility checklist as working references for design, content, and quality assurance.

What should work

The public site is designed so that users should be able to:

  • navigate the main pages with a keyboard;
  • skip directly to the main content;
  • zoom and reflow the site on smaller screens;
  • understand page structure through semantic headings and landmarks;
  • read text with sufficient colour contrast;
  • use labelled form fields on contact and demo request pages;
  • access support pages with descriptive titles and embedded video titles.

Known limitations

We are still reviewing and improving the site. Known limitations include:

  • embedded YouTube videos depend on YouTube's player accessibility and may not all have full captions or text transcripts yet;
  • some support content would benefit from additional plain-language summaries and printable step-by-step guides;
  • manual testing with screen readers, voice control, and users with cognitive or communication impairments is still required before claiming full compliance;
  • the CMS admin area is provided by a third-party tool and is intended only for internal content editing, not public use.

Feedback and contact

If you find an accessibility problem, need information in another format, or have difficulty using any part of the website, please contact us through the contact page or email info@nudgereality.com.

We will review accessibility feedback and prioritise fixes that affect access to product information, support materials, or contact routes.

Review status

This statement was prepared on 18 May 2026. The site has had an internal accessibility audit against WCAG 2.2 AA and NHS guidance, but it still needs formal manual assistive technology testing before being described as fully compliant.